{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T06:15:28Z","timestamp":1783318528786,"version":"3.54.6"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fermentable dietary fibers, or microbiota-accessible carbohydrates (MACs), are hypothesized to enhance responsiveness to immune checkpoint blockade (ICB) therapy in breast cancer (BC) by increasing fecal short-chain fatty acid (SCFA) production. However, existing research findings have been inconsistent. Given that hormone-sensitive breast cancer is highly influenced by estrogen levels, the presence of estrogenic isoflavones in certain MAC sources may partially account for these discrepancies. Consequently, investigating the roles of isoflavones versus MACs in BC models is warranted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      C57BL\/6Tac mice were fed low-MAC (AIN93G), low-MAC supplemented with isoflavone genistein, high-MAC (5V5M), or high-MAC isoflavone (high-MACi; 5058D) diet to assess anti-PD1 efficacy against E0771 triple-negative breast cancer (TNBC) and 7,12-dimethylbenz[a]anthracene (DMBA)-initiated estrogen receptor \u03b1-positive (ER\u03b1\n                      <jats:sup>+<\/jats:sup>\n                      ) mammary tumors. Effects of blocking ER\u03b1 with tamoxifen (TAM) and dietary impact on the gut microbiome and immune signaling (NanoString) were also evaluated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      High-MAC diets increased fecal microbial diversity, the abundances of SCFA-producing families, and fecal SCFA levels, compared with the low-MAC diet. Anti-PD1 was effective in TNBC models with high-MAC or low-MAC diets, but responsiveness was eliminated by the inclusion of isoflavones (high MACi) or genistein (low MAC). Anti-PD1 reduced exhausted CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells in high-MAC-fed mice but increased them in high-MACi-fed mice. ER\u03b1\n                      <jats:sup>+<\/jats:sup>\n                      tumors were resistant to anti-PD1. TAM induced sensitivity to anti-PD1 in both TNBC and ER\u03b1\n                      <jats:sup>+<\/jats:sup>\n                      models possibly by modulating TH17 pathways.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our results highlight the role of diet in impacting the effectiveness of ICB therapies. Increased SCFA alone is not predictive of response to anti-PD1, but if the tumor expresses ER\u03b1 or if the diet contains ER\u03b1-activating compounds, such as isoflavones, blocking ER\u03b1\n                      <jats:sup>+<\/jats:sup>\n                      might convert unresponsive tumors responsive to anti-PD1.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1835466","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T05:38:52Z","timestamp":1783316332000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Isoflavones impair anti-PD1 efficacy in breast cancer, regardless of dietary fiber or fecal short-chain fatty acid levels"],"prefix":"10.3389","volume":"17","author":[{"given":"Fabia de Oliveira","family":"Andrade","sequence":"first","affiliation":[{"name":"The Hormel Institute, University of Minnesota","place":["Austin, MN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerrie B.","family":"Bouker","sequence":"additional","affiliation":[{"name":"Georgetown University Medical Center","place":["Washington, DC, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melike","family":"Ozgul-Onal","sequence":"additional","affiliation":[{"name":"The Hormel Institute, University of Minnesota","place":["Austin, MN, United States"]},{"name":"Department of Histology-Embryology, Medicine, Mugla Sitki Kocman University","place":["Mentese, Mugla, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Jin","sequence":"additional","affiliation":[{"name":"The Hormel Institute, University of Minnesota","place":["Austin, MN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idalia","family":"Cruz","sequence":"additional","affiliation":[{"name":"Georgetown University Medical Center","place":["Washington, DC, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Helferich","sequence":"additional","affiliation":[{"name":"Department of Food Science and Human Nutrition, University of Illinois Urbana-Champaign","place":["Urbana, IL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Gao","sequence":"additional","affiliation":[{"name":"The Hormel Institute, University of Minnesota","place":["Austin, MN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla Andrade","family":"de Oliveira","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Pharmacology, Federal University of Piaui","place":["Teresina, PI, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Verma","sequence":"additional","affiliation":[{"name":"The Hormel Institute, University of Minnesota","place":["Austin, MN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Staley","sequence":"additional","affiliation":[{"name":"Department of Surgery, Medical School, University of Minnesota","place":["Minneapolis, MN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia L.","family":"Foley","sequence":"additional","affiliation":[{"name":"Georgetown University Medical Center","place":["Washington, DC, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Hilakivi-Clarke","sequence":"additional","affiliation":[{"name":"The Hormel Institute, University of Minnesota","place":["Austin, MN, United States"]},{"name":"Depatment of Food Science and Nutrition, University of Minnesota","place":["Minneapolis, MN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaz7015","article-title":"Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response","volume":"374","author":"Spencer","year":"2021","journal-title":"Science"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/nqy041","article-title":"Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis","volume":"107","author":"So","year":"2018","journal-title":"Am J Clin Nutr"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.2895","article-title":"Association of short-chain fatty acids in the gut microbiome with clinical response to treatment with nivolumab or pembrolizumab in patients with solid cancer tumors","volume":"3","author":"Nomura","year":"2020","journal-title":"JAMA Netw Open"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1038\/s41467-021-24331-1","article-title":"Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer","volume":"12","author":"Luu","year":"2021","journal-title":"Nat Commun"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-24-4378","article-title":"Dietary fiber lacks a consistent effect on immune checkpoint blockade efficacy across diverse murine tumor models","volume":"85","author":"Roichman","year":"2025","journal-title":"Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2014.07.003","article-title":"Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates","volume":"20","author":"Sonnenburg","year":"2014","journal-title":"Cell Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3780282","article-title":"Animal models impacted by phytoestrogens in commercial chow: implications for pathways influenced by hormones","volume":"81","author":"Brown","year":"2001","journal-title":"Lab Invest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20071714","article-title":"Polyphenols as immunomodulatory compounds in the tumor microenvironment: friends or foes","volume":"20","author":"Focaccetti","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1158\/2159-8290.cd-16-0502","article-title":"Tumor cell-independent estrogen signaling drives disease progression through mobilization of myeloid-derived suppressor cells","volume":"7","author":"Svoronos","year":"2017","journal-title":"Cancer Discov"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1172\/jci151347","article-title":"Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma","volume":"131","author":"Chakraborty","year":"2021","journal-title":"J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.1038\/s41467-019-13571-x","article-title":"Sexual dimorphism and the role of estrogen in the immune microenvironment of liver metastases","volume":"10","author":"Milette","year":"2019","journal-title":"Nat Commun"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.21221","article-title":"Induction of regulatory T cells by physiological level estrogen","volume":"214","author":"Tai","year":"2008","journal-title":"J Cell Physiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1038\/s41467-020-15679-x","article-title":"Sex-associated molecular differences for cancer immunotherapy","volume":"11","author":"Ye","year":"2020","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"publisher","first-page":"105415","DOI":"10.1016\/j.jsbmb.2019.105415","article-title":"Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy","volume":"193","author":"Marquez-Garban","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1258\/002367707779399428","article-title":"How isoflavone levels in common rodent diets can interfere with the value of animal models and with experimental results","volume":"41","author":"Jensen","year":"2007","journal-title":"Lab Anim"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3601","article-title":"Systematic improvement of amplicon marker gene methods for increased accuracy in microbiome studies","volume":"34","author":"Gohl","year":"2016","journal-title":"Nat Biotechnol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1128\/aem.01541-09","article-title":"Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities","volume":"75","author":"Schloss","year":"2009","journal-title":"Appl Environ Microbiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s40168-018-0549-6","article-title":"Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation","volume":"6","author":"Staley","year":"2018","journal-title":"Microbiome"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.2842","article-title":"Alternative method for gas chromatography-mass spectrometry analysis of short-chain fatty acids in faecal samples","volume":"35","author":"Garcia-Villalba","year":"2012","journal-title":"J Sep Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.9b00640","article-title":"Skyline for small molecules: a unifying software package for quantitative metabolomics","volume":"19","author":"Adams","year":"2020","journal-title":"J Proteome Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198202000-00013","article-title":"Cells mediating graft rejection in the mouse. II. The Ly phenotypes of cells producing tumor allograft rejection","volume":"33","author":"Loveland","year":"1982","journal-title":"Transplantation"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan4488","article-title":"Eradication of spontaneous Malignancy by local immunotherapy","volume":"10","author":"Sagiv-Barfi","year":"2018","journal-title":"Sci Transl Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-18-0063","article-title":"The challenges of modeling hormone receptor-positive breast cancer in mice","volume":"25","author":"Ozdemir","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1038\/s41467-020-17644-0","article-title":"Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer","volume":"11","author":"Buqu\u00e9","year":"2020","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007117","article-title":"New hormone receptor-positive breast cancer mouse cell line mimicking the immune microenvironment of anti-PD-1 resistant mammary carcinoma","volume":"11","author":"Perez-Lanzon","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-18-2614","article-title":"Pan-TAM tyrosine kinase inhibitor BMS-777607 enhances anti-PD-1 mAb efficacy in a murine model of triple-negative breast cancer","volume":"79","author":"Kasikara","year":"2019","journal-title":"Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.175320","article-title":"Evaluating immunotherapeutic outcomes in triple-negative breast cancer with a cholesterol radiotracer in mice","volume":"9","author":"Ciavattone","year":"2024","journal-title":"JCI Insight"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/cells12060961","article-title":"Social isolation activates dormant mammary tumors, and modifies inflammatory and mitochondrial metabolic pathways in the rat mammary gland","volume":"12","author":"Andrade","year":"2023","journal-title":"Cells"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9993.1993.tb00438.x","article-title":"Non-parametric multivariate analyses of changes in community structure","volume":"18","author":"Clarke","year":"1993","journal-title":"Aust J Ecol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1890\/12-2010.1","article-title":"PERMANOVA, ANOSIM, and the Mantel test in the face of heterogeneous dispersions: what null hypothesis are you testing","volume":"83","author":"Anderson","year":"2013","journal-title":"Ecol Monogr"},{"key":"B32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.2041-210x.2011.00127.x","article-title":"Distance-based multivariate analyses confound location and dispersion effects","volume":"3","author":"Warton","year":"2012","journal-title":"Methods Ecol Evol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2002806117","article-title":"A bilateral tumor model identifies transcriptional programs associated with patient response to immune checkpoint blockade","volume":"117","author":"Chen","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1210\/me.2007-0356","article-title":"Estrogen receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding","volume":"22","author":"Chang","year":"2008","journal-title":"Mol Endocrinol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1124\/mol.54.1.105","article-title":"Differential response of estrogen receptor \u03b1 and estrogen receptor \u03b2 to partial estrogen agonists\/antagonists","volume":"54","author":"Barkhem","year":"1998","journal-title":"Mol Pharmacol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/endo.139.10.6216","article-title":"Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta","volume":"139","author":"Kuiper","year":"1998","journal-title":"Endocrinology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6425","article-title":"The immune microenvironment characterisation and dynamics in hormone receptor-positive breast cancer before and after neoadjuvant endocrine therapy","volume":"12","author":"Oner","year":"2023","journal-title":"Cancer Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12994","article-title":"Double-edged effects of tamoxifen-in-oil-gavage on an infectious murine model for multiple sclerosis","volume":"31","author":"Hulskotter","year":"2021","journal-title":"Brain Pathol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"13451","DOI":"10.1038\/s41598-019-49943-y","article-title":"Impact of systemic therapy on circulating leukocyte populations in patients with metastatic breast cancer","volume":"9","author":"Larsson","year":"2019","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2014.11.015","article-title":"Estrogen receptors in breast carcinogenesis and endocrine therapy","volume":"418","author":"Huang","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01698-2","article-title":"Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1","volume":"28","author":"McCulloch","year":"2022","journal-title":"Nat Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.06.019","article-title":"Gut-microbiota-targeted diets modulate human immune status","volume":"184","author":"Wastyk","year":"2021","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"17784","DOI":"10.1038\/s41598-020-74460-8","article-title":"Nutritional profile of rodent diets impacts experimental reproducibility in microbiome preclinical research","volume":"10","author":"Tuck","year":"2020","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0293487","article-title":"Grain versus AIN: common rodent diets differentially affect health outcomes in adult C57BL\/6j mice","volume":"19","author":"Schipper","year":"2024","journal-title":"PloS One"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1110235","article-title":"Determination of short-chain fatty acids as putative biomarkers of cancer diseases by modern analytical strategies and tools: a review","volume":"13","author":"Chalova","year":"2023","journal-title":"Front Oncol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.chom.2025.04.022","article-title":"Microbiota-derived urocanic acid triggered by tyrosine kinase inhibitors potentiates cancer immunotherapy efficacy","volume":"33","author":"Zhang","year":"2025","journal-title":"Cell Host Microbe"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-026-02292-x","article-title":"Gut microbiome modulates breast cancer risk in socially isolated mice","author":"De Oliveira Andrade","year":"2026","journal-title":"Breast Cancer Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3295","article-title":"EO771, is it a well-characterized cell line for mouse mammary cancer model? Limit and uncertainty","volume":"9","author":"Le Naour","year":"2020","journal-title":"Cancer Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001932","article-title":"Estrogen receptor beta signaling in CD8(+) T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switch","volume":"9","author":"Yuan","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B51","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13058-019-1218-9","article-title":"Immune gene expression profiling reveals heterogeneity in luminal breast tumors","volume":"21","author":"Zhu","year":"2019","journal-title":"Breast Cancer Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1038\/s41467-020-17414-y","article-title":"Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer","volume":"11","author":"Terranova-Barberio","year":"2020","journal-title":"Nat Commun"},{"key":"B53","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41467-022-35238-w","article-title":"A comprehensive single-cell map of T cell exhaustion-associated immune environments in human breast cancer","volume":"14","author":"Tietscher","year":"2023","journal-title":"Nat Commun"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-17-3452","article-title":"Safety and antitumor activity of pembrolizumab in patients with estrogen receptor-positive\/human epidermal growth factor receptor 2-negative advanced breast cancer","volume":"24","author":"Rugo","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29586","article-title":"An estrogen-associated dietary pattern and breast cancer risk in the Swedish Mammography Cohort","volume":"137","author":"Harris","year":"2015","journal-title":"Int J Cancer"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31387","article-title":"A dietary pattern based on estrogen metabolism is associated with breast cancer risk in a prospective cohort of postmenopausal women","volume":"143","author":"Guinter","year":"2018","journal-title":"Int J Cancer"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2021.03.010","article-title":"Insights into the mechanisms of Th17 differentiation and the Yin-Yang of Th17 cells in human diseases","volume":"134","author":"Zhao","year":"2021","journal-title":"Mol Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.50","article-title":"The dichotomous nature of T helper 17 cells","volume":"17","author":"Stockinger","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2024.110261","article-title":"A proximal enhancer regulates RORA expression during early human Th17 cell differentiation","volume":"264","author":"Kalim","year":"2024","journal-title":"Clin Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-11-2762","article-title":"ROR\u03b1 suppresses breast tumor invasion by inducing SEMA3F expression","volume":"72","author":"Xiong","year":"2012","journal-title":"Cancer Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1907595116","article-title":"ROR\u03b1 is crucial for attenuated inflammatory response to maintain intestinal homeostasis","volume":"116","author":"Oh","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.969476","article-title":"A comprehensive pancancer analysis reveals the potential value of RAR-related orphan receptor C (RORC) for cancer immunotherapy","volume":"13","author":"He","year":"2022","journal-title":"Front Genet"},{"key":"B63","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13046-022-02289-2","article-title":"ROR\u03b3t agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers","volume":"41","author":"Xia","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20231348","article-title":"NF-\u03baB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancer","volume":"221","author":"Lalle","year":"2024","journal-title":"J Exp Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/nature08114","article-title":"The AP-1 transcription factor Batf controls T(H)17 differentiation","volume":"460","author":"Schraml","year":"2009","journal-title":"Nature"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00964-8","article-title":"BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells","volume":"22","author":"Seo","year":"2021","journal-title":"Nat Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"S479","DOI":"10.1016\/j.annonc.2021.08.550","article-title":"267P Phase Ib\/II open-label, randomized evaluation of second- or third-line (2L\/3L) atezolizumab (atezo) + entinostat (entino) in MORPHEUS-HR+ breast cancer (M-HR+BC)","volume":"32","author":"Sonnenblick","year":"2021","journal-title":"Ann Oncol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1287824","article-title":"Update on current and new potential immunotherapies in breast cancer, from bench to bedside","volume":"15","author":"Alaluf","year":"2024","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1835466\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T05:38:53Z","timestamp":1783316333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1835466\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":68,"alternative-id":["10.3389\/fimmu.2026.1835466"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1835466","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"article-number":"1835466"}}